CLINICAL OUTCOMES OF TRANSORAL ENDOSCOPIC THYROIDECTOMY VESTIBULAR APPROACH FOR EARLY-STAGE PAPILLARY THYROID CARCINOMA AT HANOI ONCOLOGY HOSPITAL
Main Article Content
Abstract
Background: Transoral endoscopic thyroidectomy vestibular approach (TOETVA) is an advanced technique providing superior cosmetic outcomes by leaving completely scarless skin.
Objective: To evaluate the early surgical outcomes of TOETVA for papillary thyroid cancer at Hanoi Oncology Hospital. Patients and Methods: This is a descriptive retrospective/prospective series of surgical cases on 195 patients with early-stage papillary thyroid cancer cT1N0M0, who underwent TOETVA from September 2022 to March 2026 at Hanoi Oncology Hospital. Results: The mean age of the patients was 40.21 ± 8.56 years, with females accounting for 97.4%. The primary reason for admission was incidental thyroid nodules detected during routine check-ups (94.4%). The mean tumor size on ultrasound was 8.21 ± 2.5 mm, with microcarcinomas (< 10 mm) comprising 84%. Regarding surgical procedures, 92.3% of patients underwent lobectomy + isthmectomy + central neck dissection (CND), and 7.7% underwent total thyroidectomy + CND. No cases required conversion to open surgery. The mean operative time was 95 ± 7 minutes. The mean number of harvested lymph nodes was 4.98 ± 2.12, and the occult central lymph node metastasis rate was 14.9%. The most common complication was subcutaneous ecchymosis (10.8%), followed by transient hoarseness (4.1%), seroma (3.07%), and transient hypoparathyroidism (1%). No permanent complications or mental nerve injuries were recorded. The mean hospital stay was 3.75 ± 0.87 days. Conclusion: TOETVA is a feasible and safe approach for the treatment of early-stage papillary thyroid carcinoma, providing favorable early surgical outcomes and the cosmetic advantage of avoiding visible cervical scars.
Article Details
Keywords
Papillary thyroid cancer, TOETVA, Transoral endoscopic thyroidectomy, Central lymph node dissection.
References
2.Anuwong A. Transoral Endoscopic Thyroidectomy Vestibular Approach: A Series of the First 60 Human Cases. World J Surg. 2016;40(3):491-497.
3.Anuwong A, Ketwong K, Jitpratoom P, Sasanakietkul T, Duh QY. Safety and Outcomes of the Transoral Endoscopic Thyroidectomy Vestibular Approach. JAMA Surg. 2018;153(1):21-27.
4.Nguyễn Xuân Hậu, Nguyễn Xuân Hiền. Đặc điểm lâm sàng, cận lâm sàng ung thư tuyến giáp được phẫu thuật nội soi tuyến giáp qua đường miệng. Tạp chí Y học Việt Nam (VMJ). 2022;516(2).
5.Ngô Quốc Duy, Ngô Xuân Quảng. Kết quả sớm phẫu thuật nội soi tuyến giáp qua tiền đình miệng trong điều trị ung thư tuyến giáp thể nhú tại bệnh viện K. Tạp chí Y học Việt Nam (VMJ). 2021;509(2).
6.Nguyen HX, Nguyen HX, Nguyen HV, Nguyen LT, Nguyen TTP, Le QV. Transoral Endoscopic Thyroidectomy by Vestibular Approach with Central Lymph Node Dissection for Thyroid Microcarcinoma. J Laparoendosc Adv Surg Tech A. 2021;31(4):410-415.
7.Jiang WJ, Yan PJ, Zhao CL, et al. Comparison of Total Endoscopic Thyroidectomy with Conventional Open Thyroidectomy for Treatment of Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis. Surg Endosc. 2020;34(5):1891-1903.
8.Kim SY, Kim SM, Makay O, et al. Transoral endoscopic thyroidectomy using the vestibular approach with an endoscopic retractor in thyroid cancer: experience with the first 132 patients. Surg Endosc. 2020;34(12):5414-5420.
Ahn JH, Yi JW. Transoral endoscopic thyroidectomy for thyroid carcinoma: outcomes and surgical completeness in 150 single-surgeon cases. Surg Endosc. 2020;